Literature DB >> 26165057

Overlooked retained intraocular foreign body.

Antoaneta Adžić-Zečević, Edita Files-Bradarić, Mirjana Petrović.   

Abstract

INTRODUCTION: The most common cause for litigation against ophthalmologists in a trauma case is a missed intraocular foreign body (IOFB). IOFBs cause internal eye damage, but some will come to rest in the posterior segment of the eye. CASE REPORT: We presented a 57-year-old male who was referred to the ophthalmologist due to decreased visual acuity in his left eye. Slit lamp examination of his left eye showed no pathological findings. Goldmann contact lens examination showed IOFB which was lying in the vitreous body in the inferior-temporal region. Retinal rupture was noticed at 7 o'clock. The optical coherence tomography (OCT) examination was performed and it showed atrophic macular area as well as decreased peripapillar retinal fiber layers thickness. Ultrasound showed the IOFB in vitreous body cavity. History revealed that the patient had an accidental trauma, 48 years ago, when an old bomb from World War II (WWII) exploded. Due to the decrease in visual acuity and fibrosis of the vitreous body surgical intervention was performed on his left eye (phacoemulsification with intraocular lens implantation, pars plana vitrectomy and instrumental extraction of foreign body).
CONCLUSION: The intraocular foreign body (IOFB) was asymptomatic for 48 years. Symptoms depend on material and localization of the foreign body and the type of injury.

Entities:  

Mesh:

Year:  2015        PMID: 26165057     DOI: 10.2298/vsp1505463a

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  2 in total

1.  A Patient with an Inert Intraocular Foreign Body.

Authors:  Tuck Chun Ng; Pei Li Goh
Journal:  Cureus       Date:  2019-09-24

2.  Use of medical sodium hyaluronate gel in surgical removal of a glass intraocular foreign body.

Authors:  Jun Zhang; Hanyan Mao; Xi Zou; Guohua Deng
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.